Skip to main content
Figure 4 | Arthritis Research & Therapy

Figure 4

From: The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases

Figure 4

Clinically meaningful improvement in health-related quality of life. Percentage of patients who achieved a clinically meaningful improvement (≥5 points) from baseline to the first assessment time point (rheumatoid arthritis (RA): week 6 or 10, psoriatic arthritis (PsA): week 14, and ankylosing spondylitis (AS): week 12) in the physical (a) or mental (b) component summary scores of the SF-36.

Back to article page